Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Daniel L. Rolnik, David Wright, Liona C. Poon, Neil O'Gorman, Argyro Syngelaki, Catalina De Paco Matallana, Ranjit Akolekar, Simona Cicero, Deepa Janga, Mandeep Singh, Francisca S. Molina, Nicola Persico, Jacques C. Jani, Walter Plasencia, George Papaioannou, Kinneret Tenenbaum-Gavish, Hamutal Meiri, Sveinbjorn Gizurarson, Kate Maclagan, Kypros H. Nicolaides

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)11-12
Number of pages2
JournalObstetrical and Gynecological Survey
Volume73
Issue number1
DOIs
Publication statusPublished - Jan 1 2018

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Rolnik, D. L., Wright, D., Poon, L. C., O'Gorman, N., Syngelaki, A., De Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., Molina, F. S., Persico, N., Jani, J. C., Plasencia, W., Papaioannou, G., Tenenbaum-Gavish, K., Meiri, H., Gizurarson, S., Maclagan, K., & Nicolaides, K. H. (2018). Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. Obstetrical and Gynecological Survey, 73(1), 11-12. https://doi.org/10.1097/01.ogx.0000528015.09400.25